MICHELLE ELIZABETH BERGEN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care FRESNO, CA NPI 1144732017

General Payments — all program years on this page

$2,582.78

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,382.37 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,382.3712

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $372.823
Astellas Pharma US Inc $250.002
Novo Nordisk AS $125.011
Amgen Inc. $124.991
SOBI, INC $124.331
Exelixis Inc. $122.081
Janssen Biotech, Inc. $121.841
Acerta Pharma LLC $119.991
E.R. Squibb & Sons, L.L.C. $21.311

By program year

Program yearAmountRecords
2019 $40.822
2021 $268.6519
2022 $103.251
2023 $787.6916
2024 $1,382.3712

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078298009 Janssen Biotech, Inc. $121.84 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100520673 Novo Nordisk Inc $125.01 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101752095 E.R. Squibb & Sons, L.L.C. $21.31 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104464382 AstraZeneca Pharmaceuticals LP $119.99 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117202180 Amgen Inc. $124.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138573241 Exelixis Inc. $122.08 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139524494 Astellas Pharma US Inc $125.00 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139560599 Astellas Pharma US Inc $125.00 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141416766 SOBI, INC $124.33 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144972028 Takeda Pharmaceuticals U.S.A., Inc. $122.84 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144972030 Takeda Pharmaceuticals U.S.A., Inc. $124.99 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144972032 Takeda Pharmaceuticals U.S.A., Inc. $124.99 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.